NeuroscienceProceedings of the National Academy of SciencesPeer-reviewed
Cross-Platform Validation of Neurotransmitter Release Impairments in Schizophrenia Patient-Derived NRXN1-Mutant Neurons
ChangHui Pak, Tamás Dankó, Vincent R. Mirabella…·Thomas Christian Südhof
This study validates that heterozygous NRXN1 deletions impair neurotransmitter release in human neurons across multiple labs, suggesting a human-specific synaptic dysfunction relevant for schizophrenia drug discovery.